Well woman
I'll start by reading the medical library skill, then search for well woman care content.
Reading File
Finding Sources
Finding Sources
Searching the Web
well woman exam components guidelines 2025
Reading File
Finding Sources
Reading File
Reading File
Now I have comprehensive content. Let me compile the full response.
The Well-Woman Examination
Source: Textbook of Family Medicine, 9e — "Patient-Centered Approach to the Well-Woman Examination"
Purpose
The well-woman visit is an opportunity to promote health, prevent disease, and strengthen the physician-patient relationship. While traditionally centered on an annual Pap smear, modern guidelines have broadened its scope and de-emphasized the Pap as a yearly requirement. Building a trusting relationship is essential — women are more likely to disclose sensitive problems with a physician they trust, and some may have had prior negative experiences with pelvic examinations.
Evidence-Based Screening (USPSTF Grade A & B)
| Condition | Recommendation | Grade |
|---|---|---|
| Hypertension | Screen every 2 yr if BP <120/80; yearly if 120–139/80–89 mmHg | A |
| Cervical cancer (Pap smear) | Every 3 yr ages 21–65; or every 5 yr ages 30–65 with co-HPV testing | A |
| Chlamydia | All sexually active women ≤24 yr | A |
| Lipid disorders | Women ≥45 yr at increased cardiovascular risk | A |
| Colorectal cancer | Adults 50–75 yr (FOBT, sigmoidoscopy, or colonoscopy) | A |
| Tobacco use | Screen all adults; cessation interventions | A |
| HIV | Screen ages 15–65 (any age if high risk) | A |
| Breast cancer (mammography) | Every 2 yr for women 50–74 yr | B |
| Alcohol misuse | Screen + behavioral counseling | B |
| Depression | Screen when staff-assisted support is in place | B |
| Obesity | Screen; intensive behavioral/counseling interventions | B |
| Osteoporosis | Women ≥65 yr and younger women at increased risk | B |
| Type 2 diabetes | Adults with BP >135/80 mmHg | B |
| Hepatitis C | Adults born 1945–1965 | B |
| Intimate partner violence | Screen women of childbearing age | B |
| Lipid disorders | Women 20–44 yr at increased cardiovascular risk | B |
What Is NOT Recommended (potential for harm)
- Cervical cancer screening after hysterectomy for benign disease
- Gonorrhea screening in low-risk women
- Teaching breast self-examination
- Ovarian cancer screening
Pap Smear Guidelines
Key points:
- Begin Pap screening at age 21 (regardless of sexual activity onset)
- Repeat every 3 years (ages 21–65)
- Women ≥30 years: co-testing with Pap + HPV every 5 years is acceptable
- Stop at age 65 if prior results have been normal
- Women post-hysterectomy for benign disease: no screening needed
- A Pap smear is not required before starting hormonal contraception
HPV is the most common STI, with peak prevalence in the 20–24-year-old age group (~54%). Risk factors include number of sexual partners, age at first intercourse, and low socioeconomic status. Young women frequently clear HPV without intervention; older women are less likely to acquire new infections.
Immunizations
Recommended vaccines for women (per CDC/ACIP):
| Vaccine | Target Group |
|---|---|
| Tdap (tetanus, diphtheria, pertussis) | All adults |
| Influenza | Annual, all adults |
| Herpes zoster | Adults ≥50 years |
| Pneumococcal | Adults ≥65 years |
| HPV | Women ≤26 years |
Women are often caregivers for children or elderly persons who are at higher risk from vaccine-preventable illness — making immunization particularly impactful.
Abnormal Uterine Bleeding
Commonly encountered at well-woman visits. Key management principles:
- Anovulatory bleeding (unpredictable, heavy or light) results from lack of progesterone → unopposed estrogen → irregular endometrial growth
- Treatment not necessary unless the woman desires pregnancy, is symptomatic, or has anemia — but progesterone protection is required to prevent endometrial hyperplasia
- Women with chronic anovulation should have a progesterone-induced withdrawal bleed at least 4×/year (e.g., medroxyprogesterone acetate 10 mg/day × 10 days)
Treatment options by goal:
| Situation | Treatment |
|---|---|
| Pregnancy desired | Clomiphene citrate; refer to gynecology |
| Contraception desired | Combined OCP, DMPA, or levonorgestrel IUD |
| Acute outpatient bleed | High-dose OCPs up to 4 pills/day × 5–7 days; then continuous cycling × 1 month |
| Acute inpatient bleed | IV fluids, IV estrogen, surgical consultation |
Components of the Physical Examination
The well-woman visit typically includes:
- Blood pressure measurement
- BMI/weight
- Breast examination (clinical value debated for average-risk women)
- Pelvic examination (as clinically indicated)
- STI screening as appropriate
- Mental health and depression screening
- Counseling on nutrition, physical activity, tobacco, alcohol, and intimate partner violence
Textbook of Family Medicine, 9e, Chapter 25
This is a shared conversation. Sign in to Orris to start your own chat.